Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Castelli WP. Making practical sense of clinical trial data in decreasing cardiovascular risk. Am J Cardiol 2001;88:16–20.
Castelli WP, Nickerson RJ, Newell JM, Rutstein DD. Serum NEFA following fat, carbohydrate and protein ingestion and during fasting as related to intracellular lipid deposition. J Atheroscler Res 1966;6:328–341.
Castelli WP. Cholesterol and lipids in the risk of coronary artery disease—the Framingham Heart Study. Can J Cardiol 1988;4:5–10.
Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968–977.
Castelli WP, Garrison RJ, Dawber TR, McNamara PM, Feinleib M, Kannel WB. The filter cigarette and coronary heart disease: the Framingham Study. Lancet 1981;2:109–113.
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707–714.